Researchers examine prescription opioid use in patients with chronic kidney disease

October 26, 2018

San Diego, CA (October 26, 2018) -- Adults with chronic kidney disease (CKD) have not been immune to the national opioid epidemic, suggests research that will be presented at ASN Kidney Week 2018 October 23-October 28 at the San Diego Convention Center.

Patients with CKD may be more likely to receive opioid prescriptions due to a high prevalence of pain and frequent contact with healthcare systems. To uncover trends in prescription opioid use in the CKD population over time, Daniel Murphy, MD (University of Minnesota) and his colleagues analyzed 1999-2014 information on patients with CKD participating in the National Health and Nutrition Examination Survey.

In the years 1999 to 2014, adults with CKD in the United States had a higher likelihood of having an active prescription for and to be using an opioid medication compared with those without kidney disease (7.5% vs 5.4%). After statistical adjustment for demographic factors, a higher prevalence of prescription opioid use was also seen among those with CKD in the years 2011-2014 compared with 1999-2002. No effect by race/ethnicity was seen, although higher prescription opioid use was seen with females and with older age.

The researchers also found that multiple comorbid conditions were associated with higher prevalence of prescription opioid use in patients with CKD, including those known to cause pain (such as cancer and arthritis), as well those that should not directly cause pain (such as diabetes, hypertension, and obesity).

"Our research suggests the need for further work investigating the indications for opioid prescribing and the outcomes associated with use of prescription opioids in those with CKD," said Dr. Murphy.

Another study found that several environmental factors are associated with long-term prescription opioid use among elderly patients with CKD. For the study, Yun Han, MD (University of Michigan) and her colleagues analyzed a linked dataset from Medicare 5% sample claims data from 2006-2009), the American Community Survey Data from 2005-2009, and the Health Resources and Services Administration Primary Care Service Area data from 2007.

Average county-level long-term opioid use was higher in counties in the West and South compared with those in the Northeast and Midwest. Counties with aging adults and higher deprivation index tended to have greater long-term opioid use, as did counties in Medically Underserved Areas.

"Our results highlight the importance of allocating resources for this epidemic at the county level. The environmental factors identified in our study may be helpful for healthcare providers to target CKD patients at high risk of opioid abuse/dependence, and for designing local regulation and treatment for appropriate opioid use in CKD patients," said Dr. Han.
-end-
Studies: "Trends in Use of Prescription Opioids by Those with Chronic Kidney Disease in the United States, 1999 to 2014" and "Geographic and Environmental Inequities and the Prescription Opioid Epidemic among Elderly CKD Patients in the United States"

ASN Kidney Week 2018, the largest nephrology meeting of its kind, will provide a forum for more than 13,000 professionals to discuss the latest findings in kidney health research and engage in educational sessions related to advances in the care of patients with kidney and related disorders. Kidney Week 2018 will take place October 23 - October 28 at the San Diego Convention Center.  

Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 20,000 members representing 131 countries. For more information, please visit http://www.asn-online.org.

American Society of Nephrology

Related Kidney Disease Articles from Brightsurf:

Waistline matters in kidney disease
Does fat matter in kidney disease? The investigators found that all measures of higher abdominal fat content (including visceral fat, liver fat, or subcutaneous fat) and slower walk times were associated with increased levels of cardiometabolic risk factors in adults with non-dialysis dependent kidney disease.

Reducing urinary protein for patients with rare kidney disease slows kidney decline
New findings show that reducing the amount of protein in the urine of patients with focal segmental glomerulosclerosis can significantly slow declines in kidney function and extend time before patients' kidneys fail.

Antioxidant agent may prevent chronic kidney disease and Parkinson's disease
Researchers from Osaka University developed a novel dietary silicon-based antioxidant agent with renoprotective and neuroprotective effects.

Acute kidney injury and end stage kidney disease in severe COVID-19
Many COVID-19 patients experience hematuria, proteinuria and elevated serum creatinine concentration early in the course of the disease.

Genes tell a story about diabetic kidney disease
Studying Finnish genes leads to unique revelations about the development of a serious complication of diabetes, and informs an ongoing genomic study of a Singaporean cohort as part of Singapore's Diabetes Study in Nephropathy and other Microvascular Complications (DYNAMO).

New study provides insight into chronic kidney disease
Researchers have further analyzed a known signaling pathway they believe brings them one step closer to understanding the complex physiology of patients with chronic kidney disease (CKD), which might provide a path to new treatment options.

Predicting risk of chronic kidney disease
Data from about 5 million people (with and without diabetes) in 28 countries were used to develop equations to help identify people at increased five-year risk of chronic kidney disease, defined as reduced estimated glomerular filtration rate (eGFR).

A healthy diet may help prevent kidney disease
In an analysis of published studies, a healthy dietary pattern was associated with a 30% lower incidence of chronic kidney disease.

Is kidney failure a man's disease?
A new analysis of the ERA-EDTA Registry [1] reveals a striking gender difference in the incidence and prevalence of end-stage renal disease.

Chronic kidney disease: Everyone's concern
850 million people worldwide are affected by kidney disease. This worrying figure was published last June.

Read More: Kidney Disease News and Kidney Disease Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.